Congresswoman Tulsi Gabbard recently spoke on the House floor urging her colleagues to cosponsor the Medicare Drug Price Negotiation Act of 2017 to allow the Secretary of the Department.
“For far too long, Big Pharma has played by its own rules, benefiting from skyrocketing drug prices on the backs of our most vulnerable populations. Back in 2003, legislation was passed establishing Medicare Part D to make prescription drugs more affordable for people, but Big Pharma lobbyists influenced those policies and included a provision that banned the Secretary of Health and Human Services from negotiating lower prices directly with pharmaceutical companies, something that the VA can already do today.
ARTICLE CONTINUES BELOW AD
ARTICLE CONTINUES BELOW AD
“Over 42 million Americans who are enrolled in Medicare Part D continue to face rising costs on brand name drugs, fewer generic drugs, and higher premiums making it difficult, if not impossible, for many to fill their prescriptions.
“I urge my colleagues to cosponsor the Medicare Drug Price Negotiation Act to take back our healthcare from pharmaceutical companies, and allow the Secretary of HHS to negotiate drug prices directly with manufacturers to secure affordable, lifesaving medication for millions of Americans.”of Health and Human Services to negotiate directly with pharmaceutical companies under Medicare Part D to secure affordable, lifesaving prescription drug medication for millions of Americans.
This comments section is a public community forum for the purpose of free expression. Although Big Island Now encourages respectful communication only, some content may be considered offensive. Please view at your own discretion. View Comments
